Liver-specific ATP-citrate lyase inhibition by bempedoic acid decreases LDL-C and attenuates atherosclerosis
Statins are lipid-lowering drugs that prevent cardiovascular disease but tolerability is limited by severe side effects in muscles. Here the authors elucidate a liver-specific activation mechanism for bempedoic acid, a novel cholesterol-lowering drug, and show how it effectively reduces LDL-C and at...
Main Authors: | Stephen L. Pinkosky, Roger S. Newton, Emily A. Day, Rebecca J. Ford, Sarka Lhotak, Richard C. Austin, Carolyn M. Birch, Brennan K. Smith, Sergey Filippov, Pieter H.E. Groot, Gregory R. Steinberg, Narendra D. Lalwani |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2016-11-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/ncomms13457 |
Similar Items
-
Transgenic expression of ATP:citrate lyase in plants
by: Rangasamy, Dhandapani
Published: (1996) -
Autocrine/paracrine regulation of ATP citrate lyase /
by: Smith, Katherine Sue
Published: (1990) -
Exploring the Role of ATP-Citrate Lyase in the Immune System
by: Monica Dominguez, et al.
Published: (2021-02-01) -
The distribution and regulation of ATP citrate lyase in rat liver /
by: Voss, Anne Coble,
Published: (1984) -
Macrophage ATP citrate lyase deficiency stabilizes atherosclerotic plaques
by: Jeroen Baardman, et al.
Published: (2020-12-01)